Skip to main content

Diversity and Inclusion

Who Gets Access to Innovative Treatments?

In this episode of the Health & Veritas podcast, Harlan Krumholz reports on a new study testing the effectiveness of the OCD drug fluvoxamine in treating COVID, and Howard Forman reflects on the potential of continuous glucose monitoring for people with diabetes. And they’re joined by Dr. Utibe Essien of the University of Pittsburgh to discuss the barriers preventing people of color from getting innovative new treatments and medications.

Utibe Essien